Glucose Measurement clinical trials at UC Irvine
1 research study open to eligible people
Dexcom G6 Continuous Glucose Monitoring in Hemodialysis
open to eligible people ages 18 years and up
This is a pilot study enrolling adult hemodialysis patients with diabetes recruited from the University of California Irvine Medical Center (UCIMC) who will undergo simultaneous measurement of glucose levels using 1) continuous glucose monitor (CGM) measured by a Dexcom G6 device vs. 2) "gold-standard" blood glucose levels using capillary fingerstick or venous blood glucose measurements obtained on a point of care (POC) blood glucose meter. The study will assess Dexcom G6 accuracy by comparing glucose levels on the CGM device vs. blood glucose measurements in the study population.
Our lead scientists for Glucose Measurement research studies include Connie Rhee, MD, MSc Kamyar Kalantar-Zadeh, MD, MPH, PhD.